X

Trial Profile

Phase I Safety and Biodistribution Study of 124I-PEG-AVP0458 Diabody in Patients with TAG-72 Positive Ovarian and Prostate Cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 124I-PEG AVP 0458 diabody (Primary)
Indications Ovarian cancer; Prostate cancer
Focus Adverse reactions; First in man
Sponsors Avipep

Most Recent Events

21 Apr 2015 New trial record
17 Apr 2015 Status changed from recruiting to completed, according to an Avipep media release.
17 Apr 2015 Results presented at American Association for Cancer Research (AACR) annual meeting, according to an Avipep media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com